DSG3 and cancer: Increased expression of Dsg3 in cancer cell lines has been demonstrated to elicit a significant increase in the tyrosine phosphorylation of Src and its downstream targets of adherens junction proteins, E-cadherin, β-catenin and p120 with a consequence of decreased E-cadherin expression [57,97,98,99].